Data / Form D filings / Sinobiopharma, Inc.
Sinobiopharma, Inc.: Form D filing
Sinobiopharma, Inc., a biotechnology company in Nantong City, filed a Form D with the SEC in 2009. The latest, on August 27, 2009, reports $35,000 sold of a $35,000 offering to 1 investor.
Find out what Sinobiopharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8 Zhong Tian Road, Nantong City, 22600
- Phone
- 011-86-51-385328336
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2006
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1403612
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2009 | New notice | $35,000 | $35,000 | $0 | 1 | Jul 14, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Shen | Director | |
| Yuanwei Chen | Director | |
| Jianguo Wang | Director, Executive Officer | |
| Xuejun Chen | Director, Executive Officer | |
| Lequn Lee Huang | Director, Executive Officer |
Every Form D from the week of Aug 24, 2009 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sinobiopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.